News

Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and ...
In the UK, 82 fatalities have been reported to regulators—again, with no confirmed links. Ozempic and Wegovy contain the ...
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...
A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...
Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...
As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
Researchers administered weekly injections — either a placebo or semaglutide — to 800 patients across 37 countries between 2021 and 2023. More than half of participants had Type 2 diabetes ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...